Ziska holds the "Pioneership" in bringing HIGHEST number of first-ever in Bangladesh products.
Ziska pharmaceuticals ltd is the first company in Bangladesh who established segregated manufacturing facilities for penicillin, cephalosporin and other general products.
In the last decade, we have developed a number of therapeutic concepts for the first time in Bangladesh keeping in mind the need of the patients and requirement of the physicians. In 2010, we first launched Dementa (Memantine Hydrochloride) which is the most effective agent for the treatment of Alzheimer’s disease.
Then we launched Solupred (Methylprednisolone injection), a life saving steroid with a very affordable price. The tremendous success of these two products, encouraged us in such a way that launching new molecules become the passion of each and every member of our team.
Considering the demands of the young generation who are losing hair prematurely, we introduced Trugain (Minoxidil) hair spray which is the only US-FDA approved medicine for hair re-growth. Our team continued to launch a number of dermatological products like Vitilen (Methoxsalen) lotion & capsule, which is a blessing for vitiligo sufferer, Freshlook gel (Adapalene and Benzoyl peroxide gel) for severe acne, Melatrin cream (Fluocinolone acetonide, Hydroquinone and Tretinoin cream) for melasma and Dricare (Aluminium Chloride Hexahydrate) for hyperhidrosis.
Women health is a major concern to us because maternal death was a particular problem due to abortion by traditional way. Ziska is the first company to launch a product, MM Kit (Mifepristone & Misoprostol combination), which is now saving millions of women’s life each year by providing a safe medical termination of pregnancy. Again Ziska took the privilege to introduce an emergency contraceptive pill Peuli (Ulipristal Acetate 30mg), which can prevent unwanted conception up to 5 days.
Uterine fibroid is another major gynecological problem and millions of women are suffering from this problem. Surgical removal was the only curative option but after introduction of Uliroid (Ulipristal Acetate 5mg), an orally active synthetic Selective Progesterone Receptor Modulator (SPRM) morbidity associated with fibroid has been significantly reduced.
Another first time in Bangladesh product is Dexilend (Dexlansoprazole), which is the latest molecule of PPI class, which fulfils the unmet need of 24 hour acidity control.
Ziska believes that biological molecules will be dominating therapeutic options in the coming days. So now our R & D team is more focused on developing the Bio-similar molecules.